Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

NCT: NCT07089420 · COMPLETED

NCT IDNCT07089420
StatusCOMPLETED
Start Date2025-07-07
Completion2026-04-15

Brief Summary

This study is evaluating the levels of calprotectin, a protein found in stool, in healthy adults. Calprotectin is a marker of inflammation in the intestines and can help doctors tell the difference between inflammatory bowel diseases (IBD), like Crohn's disease or ulcerative colitis, and non-inflammatory conditions like irritable bowel syndrome (IBS). In this study, healthy volunteers aged 22 and older will collect a stool sample at home using a simple kit and mail it to the study site. The samples will be tested using a new laboratory method called the ALPCO Calprotectin CLIA assay. The goal is to confirm what level of calprotectin is considered "normal" in people without intestinal disease. Participation involves just one stool sample, and there are no medical procedures. Volunteers will be compensated for their time. The study will help improve how doctors interpret calprotectin test results in clinical settings.

Frequently Asked Questions

What is ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects?

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects is a clinical trial registered under NCT07089420. Current status: COMPLETED.

What is the status of NCT07089420?

The current status of NCT07089420 (ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects) is: COMPLETED.

When did ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects start?

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects started on 2025-07-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.